Cross-correlation time-frequency analysis for multiple EMG signals in Parkinson's disease: a wavelet approachDE MICHELE, Gennaro; SELLO, Stefano; CARBONCINI, Maria Chiara et al.Medical engineering & physics. 2003, Vol 25, Num 5, pp 361-369, issn 1350-4533, 9 p.Article

Modulation of disease risk according to a cathepsin D / apolipoprotein E genotype in Parkinson's diseaseSCHULTE, T; BÖHRINGER, S; SCHÖLS, L et al.Journal of neural transmission. 2003, Vol 110, Num 7, pp 749-755, issn 0300-9564, 7 p.Article

Repeated rating improves value of diagnostic dopaminergic challenge tests in Parkinson's diseaseMÜLLER, Th; BENZ, S; BÖRNKE, C et al.Journal of neural transmission. 2003, Vol 110, Num 6, pp 603-609, issn 0300-9564, 7 p.Article

Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's diseaseENGELBORGHS, S; MARESCAU, B; DE DEYN, P. P et al.Neurochemical research. 2003, Vol 28, Num 8, pp 1145-1150, issn 0364-3190, 6 p.Article

Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's diseaseDROZDZIK, Marek; BIALECKA, Monika; MYSLIWIEC, Katarzyna et al.Pharmacogenetics (London). 2003, Vol 13, Num 5, pp 259-263, issn 0960-314X, 5 p.Article

Ginsenoside Rg1 atténuâtes dopamine-induced apoptosis in PC12 cells by suppressing oxidative stressXIAO-CHUN, Chen; YUAN-GUI, Zhu; LI-AN, Zhu et al.European journal of pharmacology. 2003, Vol 473, Num 1, pp 1-7, issn 0014-2999, 7 p.Article

Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to α-synucleinFASANO, Mauro; GIRAUDO, Sabrina; COHA, Silvia et al.Neurochemistry international. 2003, Vol 42, Num 7, pp 603-606, issn 0197-0186, 4 p.Article

Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by l-3,4-dihydroxyphenylalanine (L-DOPA) and dopaminePEDROSA, R; SOARES-DA-SILVA, P.British journal of pharmacology. 2002, Vol 137, Num 8, pp 1305-1313, issn 0007-1188, 9 p.Article

Statistical analysis of multiplex brain gene expression imagesOSSADTCHI, Alex; BROWN, Vanessa M; KHAN, Arshad H et al.Neurochemical research. 2002, Vol 27, Num 10, pp 1113-1121, issn 0364-3190, 9 p.Article

Does dopamine dysfunction drive depression?MALHI, G. S; BERK, M.Acta psychiatrica scandinavica. Supplementum. 2007, Vol 115, Num 433, pp 116-124, issn 0065-1591, 9 p.Conference Paper

Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, CereportBORLONGAN, C. V; EMERICH, D. F.Brain research bulletin. 2003, Vol 60, Num 3, pp 297-306, issn 0361-9230, 10 p.Article

Inflammation and inducible nitric oxide synthase have no effect on monoamine oxidase activity in glioma cellsMAZZIO, Elizabeth; BECKER, Alan; SOLIMAN, Karam F. A et al.Biochemical pharmacology. 2003, Vol 65, Num 10, pp 1719-1727, issn 0006-2952, 9 p.Article

Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in miceBATTAGLIA, Giuseppe; BUSCETI, Carla L; PONTARELLI, Fabrizio et al.Neuropharmacology. 2003, Vol 45, Num 2, pp 155-166, issn 0028-3908, 12 p.Article

Radno pamcenje I jezicno razumijevanje U osoba S parkinsonovom bolesti = Working memory and language comprehension in patients with parkinson's diseaseROGID, Maja; KUVAC, Jelena.Govor (Zagreb). 2006, Vol 23, Num 1, pp 29-48, issn 0352-7565, 20 p.Article

Effect of fraxetin and myricetin on rotenone-induced cytotoxicity in SH-SY5Y cells: comparison with N-acetylcysteineMOLINA-JIMENEZ, M. Francisca; SANCHEZ-REUS, M. Isabel; BENEDI, Juana et al.European journal of pharmacology. 2003, Vol 472, Num 1-2, pp 81-87, issn 0014-2999, 7 p.Article

Extrastriatal dopamine D₂ receptors in Parkinson's disease: a longitudinal studyKAASINEN, V; AALTO, S; NAGREN, K et al.Journal of neural transmission. 2003, Vol 110, Num 6, pp 591-601, issn 0300-9564, 11 p.Article

Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarrayMANDEL, Silvia; GRÜNBLATT, Edna; MAOR, Gila et al.Neurochemical research. 2002, Vol 27, Num 10, pp 1231-1243, issn 0364-3190, 13 p.Article

Effect of intensive voice treatment on tone-language speakers with Parkinson's diseaseWHITEHILL, Tara L; WONG, Lina L.-N.Clinical linguistics & phonetics. 2007, Vol 21, Num 11-12, pp 919-925, issn 0269-9206, 7 p.Conference Paper

Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative diseaseDEV, Kumlesh K; HOFELE, Katja; BARBIERI, Samuel et al.Neuropharmacology. 2003, Vol 45, Num 1, pp 14-44, issn 0028-3908, 31 p.Article

Pharmacological comparison between the actions of methamphetamine and 1-aminoindan stereoisomers on sympathetic nervous function in rat vas deferensGLEZER, Sofia; FINBERG, John P. M.European journal of pharmacology. 2003, Vol 472, Num 3, pp 173-177, issn 0014-2999, 5 p.Article

Substantia nigra osmoregulation : taurine and APT involvementMORALES, Ingrid; DOPICO, Jose G; SABATE, Magdalena et al.American journal of physiology. Cell physiology. 2007, Vol 61, Num 5, issn 0363-6143, C1934-C1941Article

Classifying lower limb dynamics in Parkinson's diseaseABE, Kazuo; ASAI, Yoshiyuki; MATSUO, Yoshimi et al.Brain research bulletin. 2003, Vol 61, Num 2, pp 219-226, issn 0361-9230, 8 p.Article

Part I Parkin-associated proteins and Parkinson's diseaseDEV, Kumlesh K; VAN DER PUTTEN, Herman; SOMMER, Bernd et al.Neuropharmacology. 2003, Vol 45, Num 1, pp 1-13, issn 0028-3908, 13 p.Article

Targeting striatal cholinergic interneurons in Parkinson's disease: Focus on metabotropic glutamate receptorsPISANI, A; BONSI, P; CENTONZE, D et al.Neuropharmacology. 2003, Vol 45, Num 1, pp 45-56, issn 0028-3908, 12 p.Article

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's diseaseLORENZL, Stefan; ALBERS, David S; RELKIN, Norman et al.Neurochemistry international. 2003, Vol 43, Num 3, pp 191-196, issn 0197-0186, 6 p.Article